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1. Introduction 
This work was born from the need to verify an intuition: could platelets’ fatty acids, rather 
than the fatty acids of other cellular elements, in some way, be potential markers of Ischemic 
Cardiovascular Disease and Major Depression? For this reason a research work has been set 
up that, besides the aid of the most advanced statistical methods, has also made use of the 
Artificial Neural Networks (ANN), in the shape and form of a Self-Organizing Map (SOM). 
The aim was to compare a group of apparently healthy subjects with two groups of subjects 
with different clinical diagnoses, one of depression and the other of ischemic heart disease. 
From the statistical evidence of the numerous parameters affected, we thought it would be 
appropriate to develop the SOM. The field of investigation has been narrowed down by 
reducing it to three of the fatty acids characterizing the two diseases and the pathological 
subjects (depressed and ischemic) and the normal ones have been placed onto the map 
obtained by the SOM, clearly distinguishing one from the other. 
Naturally conjectures, hypotheses and convictions accrued from long examinations and 
discussions of the data.  
Having at our disposal two neural networks that had proven to be effective in classifying 
the two pathologies, we were naturally curious to see how the two groups would behave at 
the moment when their data were fed into the networks, but crossing them (the ones of the 
ischemic patients in the depression network and those of the depressive patients in the 
ischemic network).   
The result was found to more or less uniformly corroborate the literature data, even if, of 
course, we are aware of the fact that it will be crucial to recruit from the field significant 
samples of patients affected by both clinically verified ischemia and depression. Also, we 
must not forget that in order to get an optimum recruitment, significant samples of normal 
subjects will also have to be selected, non-cardiopathic depressives and non-depressive 
heart disease patients. The four groups will obviously have to be balanced for age and sex.  
Caution, therefore, but accompanied by the evidence, by the concordances that are 
constantly observed in the SOM and that will have to be repeatedly examined in the light of 
new and increasingly more consistent testing, that, even seems to justify the interpretative 
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possibilities of the connections between depressive illness and ischemic cardiovascular 
disease.  
The fact remains that the markers identified are the expression of the pathology of reference 
and that anyone who finds himself in the position of the network corresponding to the 
disease can be recognized to be at high risk. This could be stated much sooner than the 
moment when the clinical evidence becomes available.  
We have been comforted in this evaluation by what has been shown by some patients added 
to the test for their correspondence between clinical evidence and placing of input vectors of 
the patients’ data in the network.  
The investigations performed on other subjects, for example, children, young sportspeople, 
subjects with morphea, scleroderma etc., have shown unthinkable matches with the 
literature data relating to the risk of the diseases investigated.  
For children, in particular, an absolutely original result has been found. In other words, the 
fact that the platelet stearic acid is practically double if compared with that of all the other 
subjects, and this point, takes on great importance, precisely in the safeguarding of the child 
in respect to ischemic cardiopathy and, probably, other possible pathological phenomena. 
The child loses this condition when he or she becomes a young adult.  
To conclude, we can say that Major Depression and Cardiovascular Ischemic Disease benefit 
from an unequivocal biochemical typification that can be recognised through the 
identification of fatty acids markers of the platelets and by measuring its concentration. The 
platelets bring with them all those elements that mime the neuron and that can alternate the 
physiological hemocoagulative response, thereby actually becoming the great mediators 
between the brain and the heart.  
Before the new results, it becomes almost maniacal to search for bibliographical references 
that, for better or for worse, are (but may also not be) comforting for the statements and/or 
concepts expressed by the researcher.  
This is because novelties are always the subject of diffidence. 
Before going to press, we have detected, following a very difficult search, some working 
hypotheses in some way capable of conceptually motivating all of the work performed, 
which we report hereunder:  
- L. S. Schneider, Principles and Practice of Geriatric Psychiatry (Second Edition), 2002: 
It is important to consider that major depression is characterized and defined by descriptive - not 
biological - criteria, making it unlikely that a neurochemical finding could adequately 
characterize the disorder. Major depression is heterogeneous in its expression, possessing various 
phenomenology, family history, and course. In the elderly, a neurochemical characteristic of 
depression would have to be specific enough to distinguish from dementia, or from secondary 
depression. In addition, neurochemical differences would be expected between late-onset and 
early-onset depression, or delusional and non-delusional depression, thus helping to validate 
these putative subtypes. 
- Steven J. Garlow, M.D., Ph.D., Charles B. Nemeroff, M.D., PhD., Emory University, 
General Clinical Research Center, Period: 10/30/74 - 11/01/02, NIH:  
Platelets from depressed patients are produced in a "unregulated" state, with increased amounts 
of a number of transcripts that encode platelet specific, the result being the platelets are more 
reactive and prone to thrombus formation, 2) the platelet serotonergic system, in particular the 
5-HT2A receptor, is altered in depression which in turn contributes to the increased platelet 
reactivity observed in depression, and the relevant alteration may occur in the megakaryocytes 
and 3) alterations in the concentration of one or more humoral factors (interleukins, cytokines, 
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stress hormones) orchestrate the alterations in platelet reactivity and serotonergic functioning 
observed in depression.  
- Steven J. Garlow, M.D., Ph.D., Emory University, General Clinical Research Center, 
Period: 10/30/74 - 11/01/02, NIH:  
We hypothesize that platelet function is altered in depression resulting in platelets that are 
excessively prone to enter the clotting cascade and hence increase risk of heart disease. We have 
identified a series of megakaryocytic cell lines that express a number of platelet markers and the 
5-HT2A receptor and SERT. We have demonstrated a direct regulatory interaction between the 
5-HT2A receptor and the expression of a number of important platelet genes. Gene expression in 
megakaryocytes is regulated by a series of cytokines and growth factors including IL-3, IL-6, IL-
11, TPO, and SCF. These factors are being tested for their ability to regulate the transcription of 
the 5-HT2A and SERT genes in megakaryocytes. 
We think that we have identified, to a reasonable degree of certainty, the biochemical rules 
that govern the platelets in the diagnostic determination of Major Depression and Ischemic 
Cardiovascular Disease. Obviously, we are convinced that the disease, in this specific case 
Major Depression and Ischemic Cardiovascular Disease, is never linked just to biological 
factors but it  is always the synthesis of biology and culture, as every medical anthropology 
teaches.  
2. Medical-anthropology remarks 
“Another, not less important, goal could be that of easing the pain in mental disorders. Outside the 
medical field, the problem of the suffering due to personal and social conflicts seems to find no 
solutions. Today we tend to make no distinction and to adopt the medical modus operandi to eliminate 
every kind of inconvenience. The supporters of this trend can make use of the following fascinating 
observation: if a rise in the levels of serotonin can, for example, not only treat depression but also 
reduce aggressiveness, making the subject less shy and more confident, why don’t we try to make the 
most out of it? One could say that only a self-righteous spoilsport could deny another fellow human 
being the benefits of these miraculous medicines… 
But obviously the problem is that the choice is not clear for many different reasons. Firstly, we don’t 
know the deeper biological effects of the drugs. Secondly, the possible consequences of a drug large-
scale use are still unknown. As a third and perhaps most important point it could be argued that the 
suggested solution for the problem of personal and social suffering must tackle the causes, the origin, 
of personal and social conflicts if it is to work effectively in the long-run. Otherwise this solution will 
work for symptoms but it won’t get to the roots of the malaise.” (1)  (This passage has been 
independently translated into English from the Italian Edition: A. Damasio, L’errore di Cartesio. 
Emozioni, ragione e cervello umano, Adelphi, Milano 1995. For the official English version, see the 
English edition in the bibliography: 1).  
This dense passage by Damasio leads to two final reflections:  
- the roots of the malaise should never be considered either merely biological or merely 
psychological, but rather human, deeply human. If you approach the human pain with 
an auto-referential knowledge or with knowledge displayed as pure, it becomes 
impossible, ab origine, to understand it (in this sense, the pure biomedicine is due to 
fail);  
- the understanding of each and every human experience, especially painful experiences 
in all their polychrome, iridescent images, means understanding the meaning, that is to 
say understanding those biological, existential, ethical, cultural, spiritual dynamics 
embodied in every single way we live our lives. And yet, the assumption that it is 
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mainly up to philosophy (because of its very nature), to the arts in all their declensions, 
to theology and to religion to understand the meaning, doesn’t preclude the possibility 
of science having a say in the matter. Indeed, as the man is one, the science is one, too, 
and we are talking about human science, with its wide range of meanings: from a 
biological and chemical meaning to a spiritual one, following epistemological paths that 
cross and enrich each other, just because the man is biology and soulology, 
neurophysiology and  psychology, flesh and soul, blood and essence. So, philosophical, 
ethical or theological meanings do exist, just in the same way as biological, chemical or 
biochemical meanings exist. The biologist or the chemist who’s running tests on, for 
example, the platelet membrane fatty acids is perfectly aware, or should be aware, that 
all his work can’t be separated from the man considered as a bundle of meanings, and 
that in lab he can grasp, of all these meanings, only the biological one. The same goes 
for the philosopher or the theologian who is perfectly aware, or should be aware, that 
the theoretical, the existential or the spiritual analysis takes shape in the biological 
dimension, whose progressive cognitive exploration, in turn, enriches the spiritual 
research. But now, after this important remark, let’s come back to the biochemical 
discours. 
Platelets, Fatty Acids, Major Depression, Ischemic Cardiovascular Disease 
Numerous epidemiological and clinical data suggest that variations in the fatty acid 
composition of erythrocyte cellular membranes can be correlated with major depression. In 
particular, an alteration in the Arachidonic Acid (AA)/ Eicosapentaenoic Acid (EPA) ratio 
has been reported. The fatty acid composition of the cellular membranes determines its 
fluidity. The physical properties of the receptors and the enzymes, such as adenylate 
cyclases and the phospholipases, are influenced by the fluidity of the cellular membranes 
and these effects have a certain relevance in depression, in that the final responses to the 
neurotransmittor stimulation depends on the membrane’s equilibrium. In fact, by virtue of 
the presence of double bonds in their molecule, omega-3 fatty acids have a folded over 
structure, they occupy a higher volume and they make the membranes, apparently more 
fluid (in fact, omega 3 fatty acids are less fluidizing of omega 6 by the saturated chain length 
from the first double bond). That aspect explains, in literature, why these compounds are 
thought to be effective as anti-depressives and mood stabilizers (2, 3, 4, 5, 6). The debate is 
still open and probably the antidepressant function of omega 3 fatty acids may be attributed 
to other reasons. 
This fact is also connected to the neurochemical theories of depressive disease that see the 
involvement of various neurotransmittor systems; the new research could highlight the fact 
that the imbalance involves the receptor functions and some secondary intracellular 
messengers (7). Other authors (8) have found negative correlations between the erythrocyte 
level of EPA, positive correlations between the AA/EPA ratio in the membranes and the 
score of the Hamilton Rating Scale, which measures the severity of the depressive 
symptoms. A high proportion of AA and a low one of EPA in the erythrocyte cellular 
membranes can bring about a hyperproduction of eicosanoids that derive from the PUFA 
n6, such as the prostacyclines, leukotrienes and the inflammation mediators with an 
increase in the oxidative stress (9). 
Some further food for thought is the problem of the depression at the outset in advanced 
age. Depression has a lifetime prevalence of about 15% and most of all it affects the age-
range between 18 and 29 years. Henderson et al. (10), using the ICD10 criteria, found a 3.3% 
prevalence in the population aged over 70 years. Depression is ten times more frequent in 
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the elderly bearers of organic diseases than in the healthy ones, although specific biological 
bonds were not evidenced between the diseases. The internal diseases that are most 
frequently complicated with the outset of depressive symptoms are hypo- and 
hyperthyroidism, Cushing’s syndrome, viral infections, lymphomas, carcinomas of the 
pancreas. Even some drugs can trigger a depressive episode (reserpine, alpha-methyl-dopa, 
clonidine, propanolol, digitalis, steroids, levo-dopa, and some anti-tumor drugs). The high 
prevalence of depression during other neurological diseases such as Alzheimer’s also stands 
out (between 15% and 20% of the patients with AD diagnosis present a major depressive 
picture, up to 50% present less serious depressive symptoms), and vascular dementia, 
Parkinson’s (40%-50% of patients affected by PD present an accompanying depression that 
is not in relation to the seriousness of the motor impairment). From a symptomatological 
standpoint, the depression that occurs in advanced age is prevalently characterized by 
somatic or anxiety symptoms, rather than by a marked drop in the humoral moral tone, by a 
marked apathy, obsessive ruminations, sleep disorders. Often the symptoms of a depression 
at the outset in advanced age mimic the cognitive deterioration typical of dementia (to the 
extent that we speak of pseudo-depressive dementia), posing large problems of differential 
diagnosis (11). Although the biological bases of depression in the elderly person are not yet 
known, it is possible to hypothesize, given the symptomatic confusion with the dementia 
picture and the high incidence of major depression in the   neuro-degenerative diseases, that 
it is a question of a particular nosographic entity in relation to depression in adult age and 
that cerebral aging constitutes a factor of vulnerability (if not indeed an etiological factor). 
The new frontiers of research take into consideration the addition of omega-3 and other anti-
oxidant substances in the diet for the treatment of depression. It has been hypothesized that 
the omega 3 fatty acids have mood stabilizing properties with a mechanism akin to that of 
lithium and valproic acid, reducing the turnover of the arachidonic acid and modifying the 
transduction pathways of the neuronal signal. In their action on bipolar disorders, the 
omega-3 fatty acids largely resemble lamotrigin, that is, they seem to have stabilizing and 
anti-depressant properties (12). Biochemical studies have shown that a high-dose oral 
administration of omega-3 leads to their membrane incorporation. The increase in the  
concentration of omega-3 in the membranes seems to suppress the transduction pathways of 
the signal associated to the production of inoxitol-3-phosphate, which is the second 
messenger associated to numerous neurotransmittor systems, such as the serotoninergic one 
(rec, 5HT2). Another mechanism proposed is that of the calcium-antagonist, by means of the 
calcium channel block. Studies on this effect derive from the cardiological literature.  
Extrapolating the data on the cardiac mechanism to the SNC, an increased activity of the 
brain phospholipases can be supposed during the maniacal phases, with an increased 
release of fatty acids as second messengers, which triggers a cascade of events culminating 
in the release of calcium from the cell deposits (and the consequent activation of protein 
kinase, which in turn activate various enzymes, amongst which those dedicated to the gene 
transcription). The blocking of the calcium channels by the omega-3 could reduce a process 
of hyper-activated signal transduction (anti-kindling?). The omega-3 fatty acids also produce 
a direct inhibition of the protein kinase C (PKC), with an action akin to that of the valproate. 
Lastly, the omega-3 fatty acids inhibit the production of pro-inflammatory cytokines. The 
concomitant intake of antioxidant vitamins (Vitamins C and E) would optimize the effect of 
the omega-3, preventing their oxidation (13). Vitamin E has been used at high 
pharmacological doses in the treatment of disorders such as Parkinson’s, Alzheimer’s and 
retarded dyscinesia. Clinical studies have shown that the use of vitamin E brings benefits in 
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the treatment of AD, but that it does not have effects in retarding the progression of 
Parkinson’s and retarded dyscinesia (14). 
Melatonin also seems to have a ‘scavenger’ activity vis-à-vis the hydroxylic radicals besides 
its known properties of gonad function and biological rhythm regulation. This fact suggests 
that the melatonin could interfere with the neurodegenerative processes that affect the 
formation of free radicals and the release of amino-acid exciters (15). 
Depression and the cardiac arrhythmias are linked to the autonomous nervous system as 
has been seen in the measurement of heart beat variability.  
The transport protein of serotonin and the areas promoting the transport of serotonin 
ligands are shared by the platelets and the cerebral neurons so that central as well as 
peripheral effects may be expected.  
Platelet activation is significantly higher among the depressed patients both in the presence 
and the absence of heart disease.  
All of this shows the existence of a common path to the ischemic event both at the cerebral 
and the cardiac level by which the depression, more by the cerebral way than mental-
behavioural, increases mortality. Although the routine screening for depression in the 
conditions of primary intervention is controversial, the incidence and the effects of 
depression among the heart patients and the stroke survivors are persuasive arguments for 
performing a screening among these groups. 
While the post-MI depression has been well documented, depression as a risk factor for 
CHD remains controversial. Some studies have found a positive correlation between 
depression and the development of CHD in women alone, but other studies have found that 
depression was associated to an increase in the CHD risk in men. Confluent variables such 
as physical functions, hostility, anxiety and somatization involve evidence of a possible 
relationship between cause and effect. The parameters, the depression symptoms such as 
fatigue, the lack of interest in activities, the increase or loss of appetite, the psychomotor 
retardation or agitation, concentration disorders, low self-esteem, a depressed mood, and 
recurrent suicide attempts, can themselves be the precursors to CHD.   
Vast as well as exhaustive scientific research has been performed on the relationship 
between depression and ischemic cardiovascular disease (16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 
26, 27, 28), and it has also dealt with the study of the fatty acids evaluated in several bio-
humoral fractions of the human organism (plasma phospholipids, cholesterol esters, 
erythrocytes, etc.) in order to identify the involvement of the different acidic components, in 
particular the saturated ones, on the determinism of the atherogenetic phenomenon and of 
those aspects of hemocoagulation that induce a thrombogenetic risk (29, 30, 31, 32, 33, 34, 35, 
36, 37, 38, 39, 40). 
3. Biological plausibility of the platelet role between depression and 
cardiovascular disease - fragments from the scientific literature 
…It is well known that platelets possess metabolic capacities for fatty acid synthesis and that 
they possess the neurotransmittor receptors. These characteristics make the platelets, in the 
view of many researchers, an element akin to the neuron. With scientific simplification, a 
“fragment of circulating brain” and they differ substantially from the erythrocytes … (41) 
…The platelets perform an important role not only in the hemostasis but also in the 
physiopathology of the ischemic coronary disease. Recent results suggest that the platelets 
are affected by different stress agents including the psychological ones and that the platelets 
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offer an important advantage in the understanding of the neurophysiology of the various 
psychiatric disorders.  
Research is described relating to the use of platelets as a ground for investigating the 
relations between stress and cardiovascular disease, apart from psychopharmacological 
research. There is evidence to propose circulating platelets as a model for bioaminergic 
neurons. There are many similarities between platelets and neurons relating to the 
metabolism of serotonin, and it is possible to extend this research model to other 
neurotransmitters such as dopamine, GABA, glutamate, etc. The reason for such similarities 
can be traced back to the common embryogenetic origin of the two different cells. Some 
modifications of the platelet functions have been observed in the psychiatric syndromes and 
the bond between coronary pathology, stress and platelet function is of interest for future 
research. Other studies might look to the thrombotic events such as stroke and vascular 
dementia and their association with stress agents using the platelets as search means or 
examine the association of certain risk factors of ischemic cardiopathy, with certain 
personality traits, using platelets as the variable key… (42).  
…The comparison with the properties of human platelets and the serotoninergic 
synaptosomes may be useful as a model in the study of the transport, the metabolism and 
the release of serotonin by the serotoninergic neurons of the central nervous system (43).  
…A marked reduction in the levels of serotonin has been found in patients with major 
depressive disorder but not in the dystimic disorders. These modifications may represent 
biochemical modifications suggesting major depressive disorders and cannot be attributed 
to chronic anti-depressive treatment … (44). 
The reduction in the serotonin levels in depressive patients could be traced back to their 
psychobiological distinction, which involves an abnormal metabolism of the biogenic 
amines in the brain… (45). The identification of the peripheral markers for the psychiatric 
illnesses is important if we want to implement an improvement in the diagnosis and the 
treatment of the diseases. The response of platelet intracellular calcium consequent to the 
neurotransmitter stimulation has been used as a peripheral marker of psychiatric illness. 
There is evidence of the appropriateness of extending the use of the platelets as a peripheral 
marker. The depressed patients show a rise in the basal platelet activation as compared with 
normal subjects and an elevated susceptibility to platelet activation could be the mechanism 
that makes depression a significant risk factor for cardiovascular and cerebrovascular 
disease… (46, 47).  
…Fatty acids other than the omega 3 can interact with the metabolism of the eicosanoids 
and influence the platelet function. For example, there is evidence that diets rich in 
unsaturated fatty acids such as linoleic and oleic acid can reduce the trend to thrombosis 
replacing the Arachidonic acid in the platelet phospholipids, diminishing the in vitro 
production of the A2 thromboxanes and the platelet aggregation. Nevertheless, there is little 
evidence that the platelet function, in vivo, is affected by these diets…(48)  
There are results that show that the linoleic acid of the diet does not increase the level of 
arachidonic acid in the plasma and in the platelets besides not contributing in a persistent 
way to the prostaglandin biosynthesis that is increased by the intake of arachidonic acid 
with the Western diet… (49). An elevated intake of linoleic acid can be thought to be 
protective against ischemic stroke, possibly through a potential mechanism reducing arterial 
pressure, reducing platelet aggregation and increasing erythrocyte deformability… (50).  
… Oleic acid has been shown to be a powerful inhibitor of induced PAF platelet aggregation 
and serotonin secretion. Consequently, in order to understand the molecular action 
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mechanism of the oleic acid, the effects of this free fatty acid have been sought for in many 
biochemical events associated with the platelet aggregation induced by the PAF. 
… The decrease in the level of [32P] PIP and [32P] PIP2 determined by the oleic acid has 
been associated with an inhibition in the platelet aggregation induced by the PAF. These 
results suggest that the inhibition of the PAF response by the oleic acid may be one of the 
steps in signal transduction … 
…Many literature reports suggest that olive oil can inhibit platelet function. This possible 
effect is of interest for two reasons: it can contribute to the apparently anti-atherogenetic role 
of olive oil and can invalidate the use of olive oil as an inert placebo in the studies on 
platelet function … (51). 
…After the supplementation with olive oil the platelet aggregation and the release of A2 
thromboxane were diminished, the content of oleic acid was considerably increased, and the 
content of arachidonic acid was significantly diminished. These data suggest that an excess 
of oleic acid displaces the incorporation of the arachidonic acid in the platelet 
phospholipids. … it is concluded that the olive oil supplement exerts an inhibitor effect on 
the various aspects of platelet function, “an effect that can reduce the risk of heart disease, 
although fish intake can also exert a protective effect…” (52).  
…There is relevance in the negative effect low plasma levels of linoleic acid in the long-term 
prognosis after myocardial infarction … (53). 
…The polyunsaturated fatty acids and principally linoleic acid can have a substantially 
cardioprotective effect that is reflected in mortality. The quality of the dietary lipids seems 
more important than the quantity of the reduction in cardiovascular mortality in man… (54, 
55).  
4. The experimental design 
Not believing the research performed on the omega 3 fatty acids to be exhaustive in the 
various experimental conditions of the literature, we have oriented our research towards a 
complex tissue and in particular that of the platelets, which, for their structural and 
functional characteristics, seemed to us to better fulfil the working hypotheses of a 
mediation role between cerebral and cardiac phenomena.  
For the experimental aim of providing better knowledge on the fatty acid-depression and 
ischemic cardiovascular disease, we recruited:  
1. 84 subjects (51 females and 33 males, with mean age: 60, 21, SD ± 12.27) with clinical 
diagnosis of Major Depression. All the patients were interviewed to confirm the 
diagnosis of Major Depression; the instruments used were: Clinical Global Impression 
(CGI), Symptoms Check List-90 (SCL-90), Medical and Pharmacological history, BMI, 
Structured Clinical Interview DSM-IV-SCID-IV (American Psychiatric Association 
2000), and Hamilton Rating Scale of Depression (HRSD). 
The severity of the depressive symptoms in the group of patients was determined by 
the Hamilton Rating Scale of Depression 21 items version (HRSD-21), Hamilton 
(1960).  
2. 50 subjects (17 females and 33 males, mean age: 68, 00, SD: ± 9.50) with diagnosis of 
Ischemic Cardiovascular Disease confirmed in the hemodynamic diagnostic phase.  
3. 60 subjects (38 males and 22 females, with mean age: 33.97, SD: ± 12, 40), apparently 
healthy, with no known or referred history of depression or cardiovascular disease. 
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5. Results of the study 
The results, regarding the platelet’s fatty acid composition, after the statistical analysis, are 
expressed in Table 1 and 2. 
All the ANNs tested gave essentially the same result. However, one type of ANN, known as 
Self-Organizing Map (SOM), gave superior information by allowing the results to be 
described in a two-dimensional plane with potentially informative border areas. A series of 
repeated and independent SOM simulations, with the input parameters being changed each 
time, led to the finding that the best discriminant map was that obtained by inclusion of the 
following three fatty acids: Linoleic Acid (C18:2 n-6), Arachidonic Acid (C20:4 n-6) and 
Palmitic Acid (C16:0) for the depressive condition and Oleic Acid (C18:1), Linoleic Acid 
(C18:2 n-6) and Arachidonic Acid (C20:4 n-6) for the ischemic condition (56, 57, 58, 59, 60). 
The SOM is an unsupervised competitive-learning network algorithm, which was invented 
by Teuvo Kohonen in 1981–82. According to Kohonen et al. (61, 62, 63) the central property 
of the SOM is that it forms a nonlinear projection of a high-dimensional data manifold on a 
regular, low-dimensional (usually 2D) grid. In the display, the clustering of the data space as 
well as the metric-topological relations of the data items is clearly visible. If the data items 
are vectors, the components of which are variables with a definite meaning such as the 
descriptors of statistical data, or measurements that describe a process, the SOM grid can be 
used as a groundwork on which each of the variables can be displayed separately using 
greylevel or pseudocolor coding. This kind of combined display has been found very useful 
for the understanding of the mutual dependencies between the variables, as well as of the 
structures of the data set. In the context of this definition, a manifold refers to a topological 
space with welldefined mathematical properties. A particular strength of the SOM map 
displays lies in enabling relevant information to be 'found' rather than 'searched for'. 
The fatty acids values of the 3 groups, administered to the SOM, mixing healthy and 
pathological individuals and hiding the information on to their own pathological condition, 
 
Fatty acids Normal 
(average±SD) 
Depressive  
(average±SD) 
p 
C 14:0 0.87±0.59 1.03±0.706 N.S. 
C 16:0 20.68±2.15 17.92±4.462 < .01 
C 16:1 1.48±0.71 2.02±1.571 < .05 
C 17:1 0.80±0.540 0.45±0.267 < .01 
C 18:0 11.22±3.00 12.7±3.016 < .01 
C 18:1 n9 22.19±2.08 21.14±4.134 N.S. 
C 18:1 n7 1.82±0.64 1.89±0.870 N.S. 
C 18:2 n6 19.40±2.69 16.71±3.359 < .01 
C18:3  n3 0.48±0.17 0.73±1.554 N.S. 
C 20:3 n3 2.11±0.76 2.29±0.773 N.S. 
C 20:4 n6 14.06±2.41 19.03±3.839 < .01 
C 22:4 1.62±0.704 1.60±0.820 N.S. 
C 22:5 1.16±0.615 0.98±0.564 N.S. 
C 22:6 n3 2.09±0.80 1.49±0.802 < .01 
Table 1. Platelet fatty acids in MD 
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Fatty acids Normal 
(average±SD) 
Ischemic  
(average±SD) 
p 
C14:0 0.87±0.59 0.34±0.26 < 0.01 
C16:0 20.68±2.15 23.32±3.17 < 0.01 
C16:1 1.48±0.71 0.74±0.54 < 0.01 
C18:0 11.23±3.00 17.65±2.50 < 0.01 
C18:1 n9 22.19±2.08 17.48±2.14 < 0.01 
C18:1 n7 1.82±0.64 1.04±0.46 < 0.01 
C18:2 n6 19.41±2.69 10.51±3.44 < 0.01 
C18:3 n3 0.48±0.17 0.59±0.30 < 0.05 
C20:3 n3 2.11±0.76 0.73±0.42 < 0.01 
C20:4 n6 14.06±2.41 15.17±3.01 < 0.05 
C22:6 n3 2.09±0.80 1.87±0.70 N.S. 
Table 2. Platelet fatty acids in IHD 
gave, as a result, the separation of the different groups, respectively, Depressive vs. Normal 
and Ischemic vs. Normal, recognizing as similar those belonging to the same population 
and, in the meanwhile, different those belonging to one population from the other ones. 
An objective, clear and extremely economic diagnostic tool has been built, which beyond the 
simple healthy / diseased information, offers a range of intensity, starting from a simple 
blood test. 
When this type of situation has been noted, we thought of putting together in a SOM the 
fatty acid triplets of the subjects with Major Depression (SOM-ADAM), Ischemic Heart 
Disease (SOM-CAIN) and of the healthy subjects.  
We have thus proceeded to the phase of SOM training, which, in the end, provided its self-
organised map.  
Based on the findings of table 1 and 2, the pathologies have been classified as in figures (1, 2 
and 3): in red colour the pathological subjects in green colour the apparently normal subjects. 
 
 
Fig. 1. Classification of the Depressive Subjects   
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Fig. 2. Classification of the Ischemic Subjects 
 
 
Fig. 3. Simultaneous classification of the three groups and, highlighted, the mixed area 
depressed and ischemic subjects 
The distribution of the 144 subjects affected by the SOM for depression has allowed us to 
identify four areas: two specific ones (exclusively normal and exclusively pathological) and 
two mixed ones with different concentrations of pathological subjects and apparently 
normal subjects of the sample. The two intermediate areas (yellow and orange) have initially 
been interpreted as different possible levels of staging of the depressive disease and a 
pathological condition not diagnosed in the normal subjects, as described in the literature, 
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moreover. The capacity of this mathematical instrument to express the pathology according 
to a different scale of intensity soon appeared clear. As regards the hypothesis that the 
positioning of the cases was also the expression of a different chemico-physical condition of 
the membrane, we addressed our attention towards the possibility of identifying such a 
condition by only considering the Arachidonic, Linoleic and Palmitic acids. Among the 
different characteristics observed in these fatty acids there emerged a significant correlation 
(r = 0.66, p < 0.001) between the sum of the 2 unsaturated acids (AA+AL) as compared with 
the saturate (AP). In other words, the sum of the three fatty acids can be considered, to a fair 
degree of approximation, constant and equal to 53.33 ± 3.43 (average±SD). 
Further analysis has led us to identify an effective index (B2) that relates the saturation 
characteristics of the set of the three fatty acids (57). 
That index has been identified in the following way: 
 
 
Fig. 4. Distribution of the B2 index on the map 
That coefficient was calculated for all the 144 subjects studied. This has allowed us to further 
classify the subjects on the grounds of this index with statistical significance (comparison 
between the indices of the normal and the pathological subjects). 
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i Name 
1 Palmitic Acid C 16:0
2 Linoleic Acid C 18:2
3 Arachidonic Acid C 20:4
Where: 
Ai = percentage of i-th  Fatty Acid 
mwi = molecular weight of  i-th  Fatty Acid 
mpi = melting point of  i-th  Fatty Acid 
We then asked the SOM to express the B2 expected at every point of the map.  
6. Cardiovascular ischemic disease 
As the fatty acids identified by the network do not represent the majority of all the fatty 
acids of the acidic spectrum, we tried to identify an index that could express the saturation 
level that could most significantly be traced back to the CAIN logic (Coronary Artery 
Ischemic Neural network).  
The search for such an index has been performed by assessing the various ratio 
combinations between saturated fatty and unsaturated acids defining the result with the 
reported initials (SI = Saturation Index Total and Classic), B2, B4, Btot. Some of these are 
already known of in the literature, others are defined by the Authors. 
In this way we can define: 
 SI
TOT 
= (C14:0 + C16:0 + C18:0) / (C16:1 + C18:1n9 + C18:1n7 + C18:2 + C18:3 +C20:3 + C20:4 
+ C22:6).  
 SI
CLASSIC = C18:0 / C18:1 n9  
 B2= f (C16:0, C18:2, C20:4) 
 B4= f (C16:0, C18:0, C18:1, C20:4) 
 BTOT= f (C14:0, C16:0, C18:0, C16:1, C18:1n9, C18:2, C18:3, C20:4, C22:6)  
As can be observed in Table 3, all the parameters that express the saturation level are 
significantly and strongly correlated to each other. For the sake of simplicity of calculation 
and use, we therefore decided to use the SI Classic (hereinafter SI).  
This index, akin to the case of depression with the B2, has been put into the CAIN and, as 
can be seen (figure 5), it has cadenced the membership of the two groups in the pathological 
and normal quadrant in a way corresponding to the classification effected by the RNA. For 
that purpose, the cut-off value proposed for the SI is 0.80. 
This SI trend is distributed growingly (from the bottom to the top of the map) and is 
coherent with CAIN. While the area of the disease is observed with a very gradual 
distribution, the area of normality appears to be more non-homogeneous. That condition 
can probably be traced back to three pieces of evidence:   
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Table 3. Correlation of the identified saturation index. 
 
 
Fig. 5. Distribution of the saturation index (SI Classic) on the CAIN map colouring in red the 
subjects with SI > 0.80 and in green those with SI <= 0.80 
1. The oleic level, in any case distributed in the area of normality, is the guarantee of the 
same, nonetheless having in the lowest cut-off values; 
2. The levels of oleic acid in the area of normality must in any case take account of the 
distribution of the other fatty acids, CAIN markers. This supports the configuration 
assumed.  
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3. In the pathology area, the gradual distribution seems to suggest the position of strength 
of the oleic acid that leaves aside the value assumed by the other AG.  
It is still interesting to see how the characterisation of the oleic acid is also conditioned by a 
relationship with a fatty acid (stearic) not considered by the conventional statistical 
methods, neither by the RNA. 
7. CAIN and Framingham (The Framingham score) 
The Framingham score (61) is one of the best known diagnostic instruments suited to 
quantifying the presence of the cardiopathy risk. Constructed on a statistical basis, it is made 
up of 5 items relating to: 
a. Subject age; 
b. Total cholesterol; 
c. Smoke; 
d. HDL level; 
e. Systolic Blood Pressure; 
For each item a score is assigned, according to the value relating to the subject being 
studied, taking account of the sex (Fig. 6). 
 
 
Fig. 6. The Framingham Score 
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The total score obtained (Figure 7) is converted, by means of a Table (Table 4) into a risk 
percentage over 10 years. 
 
 
Fig. 7. The conversion of the Framingham score to a 10-year risk percentage. 
The 10-year risk percentage thus obtained can be further classified, according to what has 
been suggested by Anderson et al. (64) following the Table reported below. 
 
0 to 5% low risk 
5 to 10% moderate risk 
10 to 20% average risk 
20 to 40% high risk 
> 40% very high risk 
Table 4. Ten-year risk classification 
Now, let’s suppose we have to examine an ideal, hypothetical subject, who is in excellent 
condition: a non-smoker, perfect levels of Total Cholesterol, HDL, systolic pressure, etc. 
Although his/her health conditions are excellent, according to Framingham, he/she 
nonetheless has a risk factor: age! In other words, the fact of ageing, irrespective of 
conditions of health, in itself constitutes a risk factor. The graph of the Framingham score in 
relation to age of the ideal subject is represented in Fig. 8 (in blue). It should be pointed out 
that, as the score is different depending on the sex, the graph has been constructed using the 
mean value. Moreover, for the sake of illustration’s clarity, the linear interpolation of the 
curve has been made to overlap with that of the extrapolated curve (in red in Fig. 8). 
Let’s now consider the high risk and the very high risk levels according to Anderson’s 
classification. They are described for a ten-year risk over 20% (see Table 4). That percentage 
risk, in Framingham’s conversion table, read retrospectively, corresponds to a value of 22.5 
Framingham points, for the female population. It should be point out that we have chosen 
the female population because it is characterised by higher scores. It is worth underlining 
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Fig. 8. Graph with the age in the y-axis and the Framingham score in the x-axis. In blue: ideal 
trend of the Framingham score for a  ypothetical subject with a single risk factor: age. In red: 
the linear interpolation of the mentioned curve. 
that, in any case, by choosing the male population as reference or the mean value of the two 
sexes, the reasoning that follows does not vary quantitatively and leads to the same 
conclusion. By reporting the Framingham risk according to age, the high risk threshold and 
thus highlighting the risk area, we obtain the graph reported in Figure 9.  
 
 
Fig. 9. Graph of the Framingham score by age. In the y-axis: age of the subject; in the x-axis: 
the Framingham score. Colour gradation highlighting (orange up to red) the risk areas 
according to Anderson’s classification. 
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8. Saturation Index and CAIN 
In order to find a good index to describe synthetically the classification effected by CAIN, 
several paths have been tried. The most effective one has turned out to be that of the saturation 
indices, as reported above. In particular, the literature (65, 66) has suggested the Saturation 
Index (SI) particularly used in the oncology field, which is defined in the following way: 
 
It is possible to express the SI levels corresponding to each point of the CAIN map and 
describe then by means of a graph for level curves. In this way it is simpler to intuit the 
dynamics of SI in CAIN (Fig. 10). It should be remembered that CAIN is constructed using 
Oleic, Linoleic and Arachidonic Acid while the SI value is calculated by using Oleic Acid 
and Stearic Acid.  
 
 
CAIN Map    SI position in CAIN 
Fig. 10. On the left, the clustering of CAIN in the two areas: pathological (at the top) and 
non-pathological (at the bottom). On the right of the graph for level curves relating to the SI 
in the CAIN map. Notice how the separation curve of the clusters can be intuitively 
overlapped in the left-hand map towards the level curve of similar coordinates.  
By trying to evaluate the SI trend in CAIN (Fig. 11) we can see that it takes on minimum 
values in the lower part, corresponding to the “Normal” cluster of CAIN. From the bottom 
upwards, the value grows gradually until it reaches the maximum values in the upper part 
of the map, corresponding to the area of pathology, according to the CAIN clustering.  
9. The SI of some populations 
We have evaluated the mean values of SI in some subject populations. The first two were: 
a. “YOUNG”: Young sports people, supposedly healthy [n= 45; males = 35, females = 10; 
age = 22.7 ± 3.7 (m±SD)] 
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Fig. 11. The SI dynamic in CAIN. 
b. “ADULT”: Adults, supposedly healthy [n= 60; males = 38, females = 22; age = 34.0 ± 
12.4 (m±SD)] 
By building a graph whose y-axis had the age and whose x-axis the SI value, we obtained, 
for the two populations cited, the curve reported in Fig.12.  
 
 
Fig. 12. Graph of the SI values for 2 supposedly healthy populations of different mean ages 
Then, a third population was added: 
www.intechopen.com
Coronary Angiography 
 – Advances in Noninvasive Imaging Approach for Evaluation of Coronary Artery Disease 
 
334 
c. “DEPRESSIVE”: Subjects with clinical diagnosis of Major Depression [n=84; males = 33, 
females = 51; age = 60.2 ± 12.3 (m±SD)] 
In Figures 13 and 14 the resultant graph is shown. 
 
 
Fig. 13. Curve of the mean values of SI of the 3”, “Normal” and “populations: “Young 
Depressive” 
 
 
Fig. 14. In red: interpolation (prolonging) of the segment “Young”-“Adult”. The 
interpolation and the curve obtained in Fig. 13 can be overlapped. 
The subjects of the third group are positioned in a perfectly overlapping way with the 
interpolation (prolonging) of the segment that unites the “Young” and the “Adult” 
www.intechopen.com
Platelet, Fatty Acids, Membrane Viscosity, Depression 
and Ischemic Heart Disease - Biological-Molecular Path, with Medical-Anthropology Insights 
 
335 
population (Fig. 12). In other words, the means of the three populations are positioned (to a 
good degree of approximation) on the same line. It should be borne in mind that, while the 
“Young” and “Adult” populations are healthy subjects, the “Depressive” population is 
composed of subjects with the Major Depression syndrome, characterised, however, by 
being non-pathological from the cardiovascular standpoint. Hence, a fourth population was 
added: 
d) “Ischemic”: Subjects with diagnosis of ischemia [n= 50; males = 33, females = 17; age = 
68.0 ± 9.5 (m ± SD)]. Figure 15 reports the resulting graph. It appears evident that the 
“Ischemic” population does not result to be in line with the other populations examined 
being characterised by a far superior SI value. 
 
 
Fig. 15. Curve of the mean values of SI of the four populations: “Young”, “Normal”, 
“Depressive” and “Ischemic” 
10. SI, CAIN and the Framingham Score 
By comparing the graph constructed on the grounds of the Framingham score as opposed to 
the one relating to the SI, looking at the Figures 16 and 17 we can see some curious 
congruities. 
In fact, we can see that, by matching the curve by age obtained in the SI graph to the age 
curve obtained in the Framingham, the “Ischemic” population coincides with the “Very 
high risk” area of the Framingham score. The two graphs seem to let transpire a certain, as 
yet not well defined, similitude. 
But what is the cut-off between healthy and pathological (from the cardiopathological point 
of view) in the SI graph? 
To answer this question it is necessary to ask CAIN for help. It is important to evaluate 
which SI value corresponds to the subdivision line between the 2 clusters (“Ischemia” and 
“Normal”) that CAIN has formed (Figure 18).  
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Fig. 16. Framingham score graph 
 
 
Fig. 17. SI graph  
By overlapping the CAIN clustering with the SI level curve graph (Figure 19) we can see that 
the SI value corresponding to the separation line of the two CAIN areas is indeed SI = 0.8. 
Now it is sufficient to report on the SI graph undergoing construction, the SI value 
corresponding to 0.8. This will be the cut-off of the SI values that subdivides the 
pathological and non-pathological subjects according to CAIN. Indeed, Figure  19 clearly 
shows that values lower than 0.8 in CAIN characterise healthy subjects, as opposed to those 
superior to 0.8 which, on the contrary , identify pathological subjects. 
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Fig. 18. Evaluation of the SI value corresponding to the clustered subdivision line (“normal” 
and “Ischemia”) of CAIN. By subdivision it is observed that the line corresponds to the level 
curve of the SI graph equal to SI = 0.8. 
 
 
 
 
Fig. 19. SI and CAIN graph 
Once the areas of pathology and non-pathology are identified in the SI graph, it is 
juxtaposed with the one obtained from the Framingham (Figure 20). The match is certain. 
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Fig. 20. The Framingham score graph (on the left) and the SI graph (on the right). 
In order to better appreciate the overlap between the two graphs we propose (Figure 21) the 
overlapping obtained by coinciding the two cut-off lines. The two curves submitted overlap 
in an absolutely coherent way.  
 
 
Fig. 21. Overlap of the Framingham Score and the SI graph. On the y-axis the age, on the left 
x-axis the Framingham score values, with related curve in red; on the right x-axis the SI 
values with related curve in green. 
By overlapping the two graphs, so that the SI cut-off value matches that of the Framingham 
Score, we obtain a match of the two underlying curves (red and green).  
The following figure sums up all the positions of the individuals investigated. 
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Fig. 22. The Figure represents all the positions of the subjects studied; it can be seen how the 
swine and the children (SI) occupy an absolutely different position from the adults and even 
more detached from the ischemic patients.  
11. Conclusions 
What has been illustrated shows, at least as a first approximation, that the results obtained 
by CAIN 3 are absolutely compatible with the Framingham Score. Apart from corroborating 
the results obtained with CAIN even more, this obliges us to make a comparison between 
the two methods.  
The Framingham score, constructed on a statistical basis, offers as a result a pure number 
that quantifies a risk. Actually, it is one-dimensional. On the other hand, CAIN shows the 
result on a two-dimensional map, obviously capable of giving more information. In actual 
fact, for CAIN we have to speak of multidimensionality because once the position of a 
subject has been identified, there is a great deal of information available. Without citing it 
all, suffice it to think that it is possible to know if any ischemic pathology is characterised by 
the low level of oleic or linoleic acid. It is possible to know its SI value straight away and, at 
least at a first approximation, the Framingham value. In other words, once the coordinates 
of the subject have been identified, it is possible to decide on which plane to observe it: the 
SI plane, the fatty acid plane, for example of arachidonic acid, etc. In any case, what is 
certain is that CAIN offers much more information than the Framingham. Suffice it to think, 
for example, that for a CAIN value one can go back to its Framingham value (albeit 
approximate). If, on the contrary, we have the Framingham score we can, in no way, 
position the subject in CAIN. 
These reasons raise a question up: is it plausible to think of CAIN as a new Framingham? 
Novel markers for ischemic heart disease are under investigation by the scientific 
community at international level. 
Our work focuses on a specific platelet membrane fatty acid condition of viscosity which is 
linked to molecular aspects such as serotonin and G proteins, factors involved in vascular 
biology. 
A suggestive hypothesis is considered about the possibility to use platelet membrane viscosity, 
in relation to serotonin or, indirectly, the fatty acid profile, as indicator of ischemic risk. 
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In the case of biological membranes we use the terms of “fluidity”, “stiffness,” permeability 
“functionality”, and “stickiness”, related or connected with biological effects of considerable 
importance. 
Fluidity and viscosity are two terms used in physics with specific meaning: the viscosity is a 
dynamic property of matter and is defined as the skid resistance of two fluid layers between 
them, in a real system treated as a package of fluid layers superimposed (in slow linear 
motion), which can vary with temperature for the same molecules, while the fluidity is the 
opposite. 
Rigidity, permeability and function are, however, characteristics of the membrane and are 
terms used to describe a physical and biological membrane behavior on the physiology of 
the cell. The viscosity of the membrane, of course, is related to the composition of fatty acids 
constituting the lipid bilayer (membrane folds). With reference to the membrane folds, they 
are usually very close and the distance may be very small in the case of saturated fatty acids, 
distance which tends to increase, replacing these with unsaturated fatty acids, much more as 
they are unsaturated. 
It has been demonstrated that the membrane viscosity is a peculiar characteristic in 
depressive subjects (67, 68) and that regulates serotonin receptors uptake [69]. 
Among all its function serotonin is also involved in some aspects of cardiac events such as 
coronary artery disease, in aggregation and vasoconstriction [70, 71]. 
Platelet takes up serotonin from plasma by the serotonin transporters and it is, then, secreted 
by the platelet dense granules during platelet activation, playing a role in platelet aggregation 
and vasoconstriction of surrounding blood vessels. Recent studies suggest that intracellular 
serotonin may also play a role in platelet activation through covalent linkage to small G 
proteins, activating G protein signaling pathways and stimulating platelet aggregation [72]. 
Total serotonin levels and the number of platelets have been found significantly higher 
among patients whith coronary artery disease [70]. 
Independently of the SOM results, among all the fatty acid profiles we have investigated 
(about 350 subjects), three fatty acids (Palmitic, Linoleic and Arachidonic), unexpectedly, 
had a constant total amount (53. 33 ± 3.43) representing the larger amount of platelet 
membrane fatty acids in all cases studied. 
If we consider this fatty acid triplet instead of that one which has allowed the classification 
of the ischemic subjects we can do a further consideration. 
It means that we can, also for the ischemic subjects, calculate a new index (B3) according to 
the B2, as above explained. 
 
Fatty 
acid 
MP/Mwt
Normal 
subjects 
(average±SD)
B3 
index
Depressive 
(average±SD)
B3 
index
Ischemic 
(average±SD) 
B3 
index 
C 16:0 0.246 20.68±2.15 5.089 17.92±4.462 4.408 23.32±3.17 5.737 
C 18:2 
n6 
-0.018 19.40±2.69 -0.348 16.71±3.359 -0,301 10.51±3.44 -0.189 
C 20:4 
n6 
-0.164 14.06±2.41 -2.306 19.03±3.839 -3.121 15.17±3.01 -2.488 
   2,434  0.986  3.060 
Table 5. Value of the B3 index in the subjects studied 
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As a result we obtained an index that expresses, on the basis of fatty acids detected, a 
coefficient of viscosity.  
The result is consistent with the knowledge that relates to the membrane viscosity, 
especially platelets, in the conditions investigated (normal, ischemic and depressive). 
This could lead to the hypothesis of the possibility to evaluate the ischemic risk considering 
each fatty acid concentration, within the same, identical quantity. 
As shown in table 1 the B3 index is significantly higher (about 30%) in ischemic than in 
normal subjects and 3 times higer than in depressive subjects. 
For the properties that link membrane viscosity to the platelet serotonin receptor uptake and 
for the role of serotonin in coronary artery disease, the evaluation of the chemical-physical 
characteristic should be utilized to forecast the ischemic risk, in agreement with the 
experimental result obtained in an Ischemic Heart Disease group of subjects through the 
SOM use. 
The Issue of Neural Networks 
(Discussion with Kary B. Mullis Nobel Prize), September 21, 2007 
Let’s try this one more time, Massimo, because somewhere there must be a disconnect in our 
dialogue on this business of an un-trained neural network being able to spot the likelihood 
of coronary heart disease in a set of patients, where the only information given to the 
network, is the concentration of three lipids on their platelets, let’s just call the lipids 1, 2  
and 3. 
What I understand is that you are demonstrating that in the absence of a “training set” your 
program can pick the patients who have a high probability for a coronary problem just from 
these values.  
By a training set I mean that the values for 1, 2 and 3, paired with an independent diagnosis 
of a coronary artery problem are presented to the computer for a certain number of your 
initial group. You are claiming that a “training set” is not necessary. 
How, I ask, could that possibly work? 
Now I do realize that lipid composition on platelets could easily have something to do with 
coronary artery problems, (and clinical depression). I don’t disbelieve that they could. 
Nobody I ever heard of predicted that, but when you told me it was true, I accepted it. But 
when you explained to me that your program had discovered this relationship with no 
reference to some external standard, no training set, I was incredulous and still am.  
I simply claim that without some additional data, like a training set of data points wherein 
the lipid variables were paired with clinical outcomes or some similar KNOWN variable 
relevant to coronary artery problems, (or a super-exceptional knowledge of physiology), the 
neuronal net, which is a mathematical object, not an oracle, could know anything except 1, 2, 
and 3 (the inputs) about the patients.  
In my experience, usually, the inputs to neuronal networks, trained with known data, are 
based on something like a thousand RNA concentrations from 100 patients, such that 
humans would have trouble seeing the connections, thus the need for the computer in the 
first place. In fact if the relationship that they discover is as simple as some mathematical 
expression among three numbers, then everyone is surprised but the computer program is 
no longer necessary. The purpose of the computer was to find those particular three 
parameters out of the thousand available. The analysis of a particular clinical finding in that 
case can, thereafter, be done by a calculator. Something like this happened at a company I 
was consulting for in Savannah, wherein a very uncomplicated solution appeared from a 
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computer program called a support vector machine regarding the differential diagnosis of 
acute lymphocytic leukemia and chronic myelogenous leukemia. The input had consisted of 
several thousands of RNA levels from several hundred patients. After the result had 
appeared it did not require a computer to make the diagnosis. A human could look at just 
two relevant RNA levels, and make the call. 
Until then, which two, or whether there were only two RNA levels that held the critical data 
was not known. The support vector machine was instructed (trained) by clinical data, not 
simply the RNA levels. That’s why it worked. 
Computers are patient and capable of tedious calculations, but they are not capable, of ever 
telling you something that given great time and near-infinite patience, you could not have 
worked out yourself on a calculator. There is no discontinuity between classical 
mathematics and what is referred to as Turing Machine-like universal calculators. They are 
just fast, very fast, but not infinitely fast, or perhaps more importantly here, wise. What this 
means is that we understand how they work. There’s no mystery, only speed. 
So, if your program can always predict coronary artery conditions from three numbers 
representing the composition of three different lipids on platelets, without ever having 
being trained on a set of these variables paired with some clinical indicators, there is no way 
that a philosopher of science could legitimately say that you had not discovered something 
that was unexplainable, but clearly useful. However, its validity is purely based on 
induction, that is, it keeps working, unless Lucio can explain how it happened, and the 
process can be adapted to other applications. Most scientists, on the other hand, and I have 
to admit in this case that I fall into the latter category, would say you are damned lucky or 
you are missing something important. 
What you are doing isn’t in the commonly accepted sense, scientific. It is lacking in the 
essential quality of being largely explainable as a consequence, however subtle, of known 
facts, and therefore serving as a guide for other scientists to develop similar methods.  
If Lucio has discovered a new principle of neural nets that allows them, independently of a 
training set, to distinguish healthy coronary arteries from unhealthy coronary arteries on the 
basis of three numbers, which to a non-biologically informed computer, are only numbers, 
that principle overshadows this particular use of it by a revolutionary leap, and deserves to 
be published not only in the appropriate medical journal, but in a computer science journal 
as well. 
Given that this is the case: some new principle of neural network programming has been 
discovered and it has found ratios of three lipids that can be used to predict future 
cardiovascular problems, then congratulations are in order, BUT even in that case, I  don’t 
understand why the program is still necessary to make the diagnosis. 
In the case I mentioned earlier regarding leukemia, once the relevant genes had been 
identified, the computer program was no longer necessary.    
There is one explanation that I can imagine to account for the facts, but it brings into 
question your judgement and that of Lucio. Since there were only three variables being 
considered, it is not impossible that the relationship between them, which correlates with 
coronary heart disease, is simple enough that it could have been discovered empirically 
without the use either in the beginning or especially later of a neural net. In fact, how 
complicated can be the relationship between three numbers?  What is the computer doing?  
Why didn’t you compare by eye the three numbers in light of who was a coronary artery 
risk patient (which as you explained to me from the Framingham data was mostly just the 
age of the patients.) 
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Was something preventing you from knowing their potential coronary artery status prior to 
the computer study, which is not now preventing you from knowing that, and if not, then 
how do you evaluate your present results?  Either you know now the coronary artery risk 
and can compare it to what your computer says, or you don’t. If you do know it now then 
you can use it to validate your result. If you know it now, when did you learn it?  Were you 
unaware of it before the computer study?   
Cordially yours, 
Kary 
 
Dear Dr. Mullis, 
How are you? And what about Linda and Nancy? Everybody is ok, here in Italy.  
Well, let’s come to the point. Now I clearly understand (I hope) the misunderstandings 
between you and Massimo. I’ll try to explain. 
You wrote: 
“Let’s try this one more time, Massimo, because somewhere there must be a disconnect in our 
dialogue on this business of an un-trained neural network being able to spot the likelihood of 
coronary heart disease in a set of patients, where the only information given to the network, is the 
concentration of three lipids on their platelets, let’s just call the lipids 1, 2 and 3. 
What I understand is that you are demonstrating that in the absence of a “training set” your 
program can pick the patients who have a high probability for a coronary problem just from these 
values. By a training set I mean that the values for 1, 2 and 3, paired with an independent diagnosis 
of a coronary artery problem are presented to the computer for a certain number of your initial group. 
You are claiming that a “training set” is not necessary. 
How, I ask, could that possibly work? 
Now I do realize that lipid composition on platelets could easily have something to do with coronary 
artery problems, (and clinical depression). I don’t disbelieve that they could. Nobody I ever heard of 
predicted that, but when you told me it was true, I accepted it. But when you explained to me that 
your program had discovered this relationship with no reference to some external standard, no 
training set, I was incredulous and still am.  
I simply claim that without some additional data, like a training set of data points wherein the lipid 
variables were paired with clinical outcomes or some similar KNOWN variable relevant to coronary 
artery problems, (or a super-exceptional knowledge of physiology), the neuronal net, which is a 
mathematical object, not an oracle, could know anything except 1, 2, and 3 (the inputs) about the 
patients. “  
Kary, you are right, we had to start from a “training set”. Maybe this is the main point of the 
misunderstanding. It’s simply a problem of words, I believe. Make the call. 
Of course we started from a “training set”. About Ischemia, it is made up by 60 healthy 
subjects versus 50 patients with definite diagnosis of Ischemia. So, we had a data base of 110 
subjects. For each Subject, we had his Fatty Acids pattern (11 variables) paired with “an 
external variable”: his healthy status related to Ischemia, I mean, if the subject is pathologic 
or healthy. 
So, we absolutely started from a “Training Set”. 
I think the misunderstanding occurred when we talked about the mathematical method, the 
training process, in particular. 
Many mathematical methods, ANNs in particular, are classified into 2 big families: 
Supervised ANNs and Unsupervised ANNs, according to the training process they use. 
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1) ANNs, using a supervised training process, need the complete training set, that is, all 
variables plus the “external variable”. For example, the Multi-Layered Perceptron (usually 
using the Back propagation algorithm) is a supervised ANN, probably the most common. It 
studies the Data Base, “learning” the features of each subject, according to his “external 
variable”, which it knows. Mathematically, it builds an n-dimensional error surface linking 
all variables involved to the “external variable”. It’s called “supervised” because it corrects 
itself reducing, in an iterative way, the global error knowing the correct result, as if “a 
teacher” would correct it, at each time. 
2) ANNs using an unsupervised training process, such as the Self Organizing Map (SOM), 
just need all variables, without the “external” one.  
This is because they use a different approach: they are not trained to find the feature of the 
different “external” value. They just look at the data and try to put together similar subjects 
without considering the “external variable” (pay attention, SOMs are different from the 
common “cluster analysis”).  
A SOM is able to do so, comparing, in a particular way, all the subjects of the data base (if 
you are interested, I attach an appendix to this paper where I try to explain how a SOM 
works, but , please, read all this paper before).  
I think it could be clearer following this example. 
Suppose you want to build up a system able to recognize handwritten characters. You 
probably start from a Data Base made of characters written by different humans (of course 
with different handwritings). In this case, the “external variable” is the real alphabetical 
letter the handwritten character represents. 
You could build this system using statistical “supervised” method. But you can also use a 
SOM. In this case, you have to show to the SOM the different handwritten characters, 
MIXED AND WITHOUT TELLING WHICH ONES RAPRESENT “A”, “B”, “C” AND SO 
ON. You just hope the Net will set different characters in different areas, putting the 
handwritten characters of “A” near to each other, and far from the handwritten characters of 
“B”, “C”, and so on. If (as usually happens), once the SOM is trained, all “A” are near, all 
“B” are near and so on, the SOM is ready: it mathematically realizes that all handwritten 
“A” are similar and puts them near to each other. The SOM realizes  that “A” are different 
from “B” and put all handwritten ”B” far form “A” but, again, near to each other. I mean: 
the “external” variable in this case is the alphabetic letter, linked to any different 
handwritten character. The SOM did not know this, when it was training, and when it was 
producing the final map. Just once the map is done, an external human observes that all 
handwritten characters, linked to the alphabetic letter “A” are together! And it’s the same 
with all other letters. Just now, the human divides the map into clusters, one for each letter 
(usually using a well known mathematical method such as the “Voronoi clusterization”). 
Once the SOM is trained, if we give it a new handwritten character, it will be mapped near 
to the similar characters, very probably in the correct cluster. 
So the whole training set, at the end, is absolutely necessary. It is not, for the SOM training. 
By the way, common commercial OCR (Optical Character Recognizer) software, usually use 
really this method. Actually, a lot of common commercial software use this kind of ANN 
even for many other purposes. 
Let’s return to Ischemia. 
We had a Training set of 110 subjects. We give to a SOM the 110 subject Data Base, without 
saying who was pathologic and who was not (exactly as done with handwritten characters). 
We just told the SOM the 3 fatty acids values. 
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Once the SOM gave us the result (I mean the map), we just observed that pathological 
subjects were all mapped on the top while healthy subjects were all mapped on the bottom. 
But we observe it, not the SOM, which does not know their pathological status. I mean: just 
once the net drew its answer, I mean the map, we colour healthy with green and pathologic 
with red, and realize the result. Since, all pathologic subjects are into a cluster, while other 
are opposite, we can say that: 
all pathologic subjects are similar to each other, and different from normal, at least from 
the 3 fatty acids involved point of view. (statement 1) 
This last statement is absolutely scientific. In fact: 
- The SOM is a very common neural network, deeply known and widely used even in 
common commercial software. It appeared to the scientific community more than 20 
years ago (T. Kohonen, 1981). Actually, in the biomedical field, SOMs are widely used 
since 10 years at least, and of course, they are absolutely accepted. 
So, the protocol used, is not a mystery, nothing unexplainable, but well known and 
accepted from years. 
Maybe it’s not so popular as a logistic regression but, at least here in Italy, more popular 
than Support Vector Machines. 
- If anyone, everywhere and whenever he wants, builds up a SOM or buys it (there are 
hundreds of commercial software developing SOMs) and trains it with our training set 
(of course, without the information about the pathological status), he will find that 
pathologic subjects go to a side and healthy, opposite. Probably, he will not find exactly 
our map, but the same result for sure. In fact, a SOM, like almost all ANNs, depends on 
random starting weight and on some other parameters: as you know, being familiar 
with ANNs, each training process is always different from another! In any case, if 
someone gives the same SOM parameters we used (to tell you the truth, they are those 
suggested by the literature, so they are the first that a computer scientist would try…) 
he will have exactly the same map.  
As a result of the statement 1, we can add that the 3 fatty acids of the pathologic population 
are, in some ways, different from those of the healthy population.  
Another result is, like in the handwriting character example, that we can map a new subject, 
whose status is unknown and, according to his position on the map, according to the cluster 
he reaches, we can think that he can be considered healthy or pathologic. I E: if his position 
into the map is in the middle of all other pathologic subjects, he can be suspected to be 
pathologic, or at least it’s very probable. 
Now, another point: 
“In my experience, usually, the inputs to neuronal networks, trained with known data, are based 
on something like a thousand RNA concentrations from 100 patients, such that humans would have 
trouble seeing the connections, thus the need for the computer in the first place. In fact if the 
relationship that they discover is as simple as some mathematical expression among three numbers, 
then everyone is surprised but the computer program is no longer necessary. The purpose of the 
computer was to find those particular three parameters out of the thousand available. The analysis of 
a particular clinical finding in that case can, thereafter, be done by a calculator.”   
Well, this is not our case. In our situation we had 110 subjects, and only 11 variables 
(coupled with the pathological status, 12th variable). So our main problem wasn’t to find 
those particular parameters out of only 11 variables. Talking about Ischemia (things are 
quite different about Depression), we identified the 3 fatty acids, quite easily, by means of 
common conventional statistics (Discriminant Analysis, ANOVA and so on). 
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Once we found those 3 parameters, we wanted to study their dynamics, we wanted more 
information, a deeper knowledge of the problem and, a diagnostic tool. So we tried to use 
different mathematical tools such as “Cluster analysis”, Classification Trees, and so on, but 
in our opinion, the best one has been the SOM.  
In fact, it quickly led us to a lot of important (according to us) results. We do not use “a 
thousand RNA concentrations” but just a simple SOM. Maybe in our case, the need for the 
computer is not in the first place, maybe we could reach same results “by eye” but, as you 
say, the main feature of a calculator is speed and our main interest is the result, secondly the 
method. In any case, by eyes we can’t evaluate the 3 parameters in the same time, with the 
same speed and precision of the SOM. 
Many people are scared by the name “artificial neural network”. But ANNs are not strange 
objects at all! They are not difficult; they are accepted as useful tools from years and 
commonly used even in everyday life application. Maybe, the only trouble is the different 
approach they use, a bit different from conventional statistics. But the problem, if it exists, is 
just in our way of thinking. And, I’m sure, Kary, you have not this kind of problems at all!!!  
One more question: 
“There is one explanation that I can imagine to account for the facts, but it brings into question your 
judgement and that of Lucio. Since there were only three variables being considered, it is not 
impossible that the relationship between them, which correlates with coronary heart disease, is simple 
enough that it could have been discovered empirically without the use either in the beginning or 
especially later of a neural net. In fact, how complicated can be the relationship between three 
numbers?  What is the computer doing?  Why didn’t you compare by eye the three numbers 
in light of who was a coronary artery risk patient (which as you explained to me from the 
Framingham data was mostly just the age of the patients.)” 
Well, a computer is not necessary to guess a handwritten character!  
How complicated can be recognizing a handwritten letter? 
But I ask you: can you explain the mathematical rules in order to classify a handwritten 
character, in an easy way? Or better: a digitized character could be expressed, for example, 
with a 8x4 matrix of pixels = 32 pixels. We certainly could give a formula with 32 variables 
in order to classify a character, but all computer scientists find it more comfortable to use a 
SOM instead of a formula. And I agree with them.  
 
Well, in our problem, there are only 3 numbers, it’s true. But, when we found the SOM map, 
we just understood that using the 3 fatty acid, we could classify a patient but we absolutely 
did not know the correct rules in order to do that, yet. We realized soon that it was not a so 
simple problem. 
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Some examples of handwritten “A” in an 8x4 matrix of pixel 
I try to explain. When Massimo and I studied the “rules”, we observed that a subject was 
pathologic if parameter 1 was low while parameter 2 was medium and parameter 3 was 
high. If parameter 3 decreases, the subject is no more pathologic unless parameter 2 
increases too, but just up to a certain value, and so on. I mean that there are a lot of possible 
configurations, combinations. We agree that we could express them with pencil and paper 
but we simply find it more comfortable and clearer using a 2 dimensional map. In our 
opinion, it’s just more simple, easy and clear. 
For example, let’s think about the Body Mass Index (BMI) and its application. It’s one of the 
simplest formulas all over the world. You just have to calculate Height/Weight2 and than 
check the result in a reference table. Well, every doctor simply has stupid soft wares that do 
it. I’m sure this could be done by eye but it’s faster and maybe easier to use a computer that 
shows a graph. Of course, we translated all our results into rules, and we are using them in 
order to continue our research. But when we have to check the healthy status of a new 
subject, we find it more comfortable to use the SOM, mainly when a subject falls in our 
border-line area. 
So Kary, as you have seen, there’s no mystery, nothing is unexplainable. Everything is, in the 
commonly accepted sense, scientific. I have not discovered a new principle of neural nets 
(warning: until now!), unfortunately, because the net we used has been existing since 1981.  
Maybe the reason of this misunderstanding between you and Massimo, between you and 
us, is me. I feel really guilty and apologize, because I was not clear in my explanations with 
you. You always had to talk of mathematical questions with Massimo, who is neither a 
mathematician nor a computer scientist! I remember that, even if we didn’t have so many 
occasions to talk together in private discussions, you came to me many times, for questions, 
remarks and so on. I apologize but my main problem is that it’s very difficult to talk with 
you: I’m neither a “researcher”, and I should talk with a Nobel laureate. I know, you were 
present when I did my first lecture, and year by year you saw me grow.  
I am really sorry, Dr. Mullis, but you are considered one of the best minds all over the 
world, and I feel so small, in front of you… sorry. 
Thank you for your time, 
Sincerely, Lucio. 
Dec 17, 2007 
 
Dear Massimo, 
Lucio has clarified the situation for me. 
I now understand your work with Lucio and agree that it is a contribution to the field of 
diagnostics in cardiology which is worth pursuing. There was a communication problem. 
I did not understand that after the self-organizing map program had operated in an 
unsupervised manner on all the data from healthy and at-risk patients, sorting each 
individual set of the values for oleic, linoleic and arachadonic acid into one of 400 bins, 
according to the similarity of the relations between their components, then you, knowing 
which sets were (from independent considerations) at-risk, “colored” the 400 squares 
according to “healthy” or “at-risk.”  That input from you  took the place of informing the 
overall procedure as to which of the patterns it had found originated in healthy and not-so-
healthy patients, and logical induction allows you to assume that whenever future values 
fall into one of those categories it will be defined. 
Certainly now by examining the program statements that assign the three fatty acid 
concentrations to particular cells in your program, you could replace the program with a 
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series of “if then” statements, but I understand that computers are ubiquitous and cheap. 
Why bother. In addition, by continuing to add more data, which you know is from healthy 
or unhealthy patients you might refine your colouring pattern if that is called for. 
So the mystery is solved.  
I’m sorry to have been so much trouble. I think if scientists still refused to talk to each other 
except in Latin, such misunderstandings might not happen. But then we would all have to 
learn Latin (even Italians) and agree on how to interpret it. 
Give Lucio my best and assure him that I understand now what you are doing as a result of 
his explanation. 
I am looking forward too seeing you next year. My regards to all. 
Cordially, 
Kary 
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